372 related articles for article (PubMed ID: 26969406)
1. Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region.
Ntoumi F; Kaleebu P; Macete E; Mfinanga S; Chakaya J; Yeboah-Manu D; Bates M; Mwaba P; Maeurer M; Petersen E; Zumla A
Int J Infect Dis; 2016 May; 46():34-7. PubMed ID: 26969406
[TBL] [Abstract][Full Text] [Related]
2. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
van Maaren PJ
Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and genetic diversity of multidrug-resistant tuberculosis in East Africa.
Kidenya BR; Webster LE; Behan S; Kabangila R; Peck RN; Mshana SE; Ocheretina O; Fitzgerald DW
Tuberculosis (Edinb); 2014 Jan; 94(1):1-7. PubMed ID: 24215798
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistant tuberculosis: trends and control.
Prasad R; Gupta N; Singh M
Indian J Chest Dis Allied Sci; 2014; 56(4):237-46. PubMed ID: 25962197
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis.
Parums DV
Med Sci Monit; 2021 Aug; 27():e934292. PubMed ID: 34366429
[TBL] [Abstract][Full Text] [Related]
6. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant tuberculosis.
Zager EM; McNerney R
BMC Infect Dis; 2008 Jan; 8():10. PubMed ID: 18221534
[TBL] [Abstract][Full Text] [Related]
8. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
Houben RM; Dodd PJ
PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
[TBL] [Abstract][Full Text] [Related]
9. Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children.
Schaaf HS; Moll AP; Dheda K
Clin Chest Med; 2009 Dec; 30(4):667-83, vii-viii. PubMed ID: 19925960
[TBL] [Abstract][Full Text] [Related]
10. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis.
Sultana ZZ; Hoque FU; Beyene J; Akhlak-Ul-Islam M; Khan MHR; Ahmed S; Hawlader DH; Hossain A
BMC Infect Dis; 2021 Jan; 21(1):51. PubMed ID: 33430786
[TBL] [Abstract][Full Text] [Related]
12. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
Nourzad S; Jenkins HE; Milstein M; Mitnick CD
Int J Tuberc Lung Dis; 2017 Jan; 21(1):6-11. PubMed ID: 28157458
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.
Dye C; Scheele S; Dolin P; Pathania V; Raviglione MC
JAMA; 1999 Aug; 282(7):677-86. PubMed ID: 10517722
[TBL] [Abstract][Full Text] [Related]
14. Management of Multidrug-Resistant Tuberculosis.
Daley CL; Caminero JA
Semin Respir Crit Care Med; 2018 Jun; 39(3):310-324. PubMed ID: 30071546
[TBL] [Abstract][Full Text] [Related]
15. [Multidrug-resistant tuberculosis].
Alcaide F; SantÃn M
Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():54-60. PubMed ID: 19100168
[TBL] [Abstract][Full Text] [Related]
16. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
[TBL] [Abstract][Full Text] [Related]
17. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of tuberculosis and multidrug resistant tuberculosis in the Middle East Region.
Ahmad S; Mokaddas E; Al-Mutairi NM
Expert Rev Anti Infect Ther; 2018 Sep; 16(9):709-721. PubMed ID: 30173588
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]